ArriVent BioPharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INFINITUM ASSET MANAGEMENT, LLC | 02/17/2026 | 4.12 M | $82.97 M | 6.59% | 9.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 4.11 M | $82.61 M | 10.87% | 9.80% |
| HHLR ADVISORS, LTD. | 02/17/2026 | 3.93 M | $79.05 M | -12.39% | 9.37% |
| FMR LLC | 02/17/2026 | 3.70 M | $74.52 M | 8.69% | 8.84% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 3.03 M | $60.91 M | 0.00% | 7.22% |
| BLACKROCK, INC. | 02/12/2026 | 2.37 M | $47.74 M | 15.97% | 5.66% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 1.97 M | $39.66 M | 0.00% | 4.70% |
| NOVO HOLDINGS A/S | 02/17/2026 | 1.94 M | $39.08 M | 0.00% | 4.63% |
| VANGUARD GROUP INC | 01/29/2026 | 1.87 M | $37.61 M | -7.90% | 4.46% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.70 M | $34.14 M | 0.00% | 4.05% |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 02/17/2026 | 1.49 M | $30.08 M | 0.00% | 3.57% |
| STATE STREET CORP | 02/13/2026 | 1.09 M | $21.97 M | 6.26% | 2.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 753.52 K | $15.16 M | 5.20% | 1.80% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 742.53 K | $14.94 M | 71.91% | 1.77% |
| SC CHINA HOLDING LTD | 02/13/2026 | 663.31 K | $16.72 M | 0.00% | 1.58% |
| 02/05/2026 | 644.79 K | $12.97 M | 100.00% | 1.54% | |
| FUND 1 INVESTMENTS, LLC | 02/17/2026 | 565.85 K | $11.38 M | -8.71% | 1.35% |
| CITADEL ADVISORS LLC | 02/17/2026 | 458.50 K | $9.23 M | 100.00% | 1.09% |
| UBS GROUP AG | 01/29/2026 | 450.92 K | $9.07 M | -9.38% | 1.08% |
| 02/17/2026 | 338.00 K | $6.80 M | 100.00% | 0.81% | |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 281.95 K | $5.67 M | -1.45% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 250.59 K | $5.04 M | 2.92% | 0.60% |
| NORTHERN TRUST CORP | 02/17/2026 | 245.60 K | $4.94 M | 6.24% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 242.83 K | $4.89 M | 100.00% | 0.58% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 233.32 K | $4.69 M | 100.00% | 0.56% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 216.66 K | $4.36 M | 100.00% | 0.52% |
| ROSALIND ADVISORS, INC. | 02/12/2026 | 215.87 K | $4.34 M | 100.00% | 0.52% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 186.49 K | $3.75 M | 45.35% | 0.45% |
| HIDDEN LAKE ASSET MANAGEMENT LP | 02/17/2026 | 152.45 K | $3.07 M | -51.46% | 0.36% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 150.00 K | $3.02 M | 100.00% | 0.36% |
| WOODLINE PARTNERS LP | 02/17/2026 | 147.39 K | $2.97 M | -50.36% | 0.35% |
| BARCLAYS PLC | 02/13/2026 | 129.17 K | $2.60 M | -0.59% | 0.31% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 118.49 K | $2.38 M | 100.00% | 0.28% |
| JANE STREET GROUP, LLC | 02/12/2026 | 103.26 K | $2.08 M | 100.00% | 0.25% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 100.00 K | $2.01 M | 0.00% | 0.24% |
| MARSHALL WACE, LLP | 02/13/2026 | 98.98 K | $1.99 M | -45.08% | 0.24% |
| MORGAN STANLEY | 02/13/2026 | 97.59 K | $1.96 M | -75.11% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 82.28 K | $1.66 M | 0.65% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 77.48 K | $1.56 M | -15.52% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 73.11 K | $1.47 M | 15.53% | 0.17% |
| JPMORGAN CHASE & CO | 02/11/2026 | 69.39 K | $1.40 M | 395.99% | 0.17% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 60.13 K | $1.21 M | 66.40% | 0.14% |
| MOODY ALDRICH PARTNERS LLC | 01/30/2026 | 56.66 K | $1.14 M | -4.70% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 56.52 K | $1.14 M | 22.93% | 0.13% |
| NUVEEN, LLC | 02/12/2026 | 53.62 K | $1.08 M | 12.49% | 0.13% |
| HRT FINANCIAL LP | 02/12/2026 | 53.42 K | $1.07 M | 100.00% | 0.13% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 51.44 K | $1.04 M | 39.24% | 0.12% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 45.56 K | $916.63 K | 511.19% | 0.11% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 43.03 K | $865.76 K | 100.00% | 0.10% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 40.30 K | $744.34 K | 100.00% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ArriVent BioPharma Inc. institutional Ownership - FAQ's
During the previous two years, 144 institutional investors and hedge funds held shares of ArriVent BioPharma Inc.. The most heavily invested institutionals were:
UBS Group AG: 486,263
VANGUARD FIDUCIARY TRUST CO: 217,127
DIMENSIONAL FUND ADVISORS LP: 126,525
E Fund Management Co., Ltd.: 93,953
Bank of New York Mellon Corp: 75,448
Nuveen, LLC: 56,839
95.69% of ArriVent BioPharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 41.23 M shares in the last 24 months. This purchase volume represents approximately $1.02 B in transactions.